Get this document via a secure connection
The NCI will no longer support CancerMail after November 2002. If you have comments about the NCI's cancer information delivery services, contact us by e-mail at cancer.govstaff@mail.nih.gov or call 301-496-9096.
###########################################################################
Most head and neck cancers begin in the squamous cells that
line the structures found in the head and neck. Because of this,
head and neck cancers are often referred to as squamous cell
carcinomas. Some head and neck cancers begin in other types of
cells. For example, cancers that begin in glandular cells are
called adenocarcinomas.
Cancers of the head and neck are further identified by the area in
which they begin:
Oral cavity--The oral cavity includes the lips, the front
two-thirds of the tongue, the gums (gingiva), the lining inside
the cheeks and lips (buccal mucosa), the bottom (floor) of the
mouth under the tongue, the bony top of the mouth (hard
palate), and the small area behind the wisdom teeth.
Salivary glands--The salivary glands are in several places:
under the tongue, in front of the ears, and under the jawbone, as
well as in other parts of the upper digestive tract.
Paranasal sinuses and nasal cavity--The paranasal sinuses are
small hollow spaces in the bones of the head surrounding the nose.
The nasal cavity is the hollow space inside the nose.
Pharynx--The pharynx is a hollow tube about 5 inches long that
starts behind the nose and leads to the esophagus (the tube
that goes to the stomach) and the trachea (the tube that
goes to the lungs). The pharynx has three parts:
Nasopharynx--The nasopharynx, the upper part of the pharynx, is
behind the nose.
Oropharynx--The oropharynx is the middle part of the pharynx.
The oropharynx includes the soft palate (the back of the mouth),
the base of the tongue, and the tonsils.
Hypopharynx--The hypopharynx is the lower part of the pharynx.
Larynx--The larynx, also called the voicebox, is a short
passageway formed by cartilage just below the pharynx in the
neck. The larynx contains the vocal cords. It also has a small
piece of tissue, called the epiglottis, which moves to cover
the larynx to prevent food from entering the air passages.
Lymph nodes in the upper part of the neck--Sometimes, squamous
cancer cells are found in the lymph nodes of the upper neck when
there is no evidence of cancer in other parts of the head and
neck. When this happens, the cancer is called metastatic squamous
neck cancer with unseen (occult) primary.
Cancers of the brain, eye, and thyroid usually are not
included in the category of head and neck cancers. Cancers of the
scalp, skin, muscles, and bones of the head and neck are also
usually not considered cancers of the head and neck.
3. How common are head and neck cancers?
Other risk factors for cancers of the head and neck include the following:
Oral cavity--Sun exposure (lip); human papillomavirus (HPV) infection.
Salivary glands--Radiation to the head and neck. This exposure can come from diagnostic x-rays or from radiation therapy for noncancerous conditions or cancer.
Paranasal sinuses and nasal cavity--Certain industrial exposures, such as wood or nickel dust inhalation. Tobacco and alcohol use may play less of a role in this type of cancer.
Nasopharynx--Asian, particularly Chinese, ancestry;
Epstein-Barr virus infection; occupational exposure to wood dust; and consumption of certain preservatives or salted foods.
Oropharynx--Poor oral hygiene, mechanical irritation such as from poorly fitting dentures, and use of mouthwash that has a high alcohol content.
Hypopharynx--Plummer-Vinson (also called Paterson-Kelly) syndrome, a rare disorder that results from nutritional deficiencies. This syndrome is characterized by severe anemia and leads to difficulty swallowing due to webs of tissue that grow across the upper part of the esophagus.
Larynx--Exposure to airborne particles of asbestos, especially in the workplace.
People who are at risk for head and neck cancers should talk with their doctor about ways they can reduce their risk. They should also discuss how often to have checkups.
Salivary glands--Swelling under the chin or around the jawbone;
numbness or paralysis of the muscles in the face; or pain that
does not go away in the face, chin, or neck.
Oropharynx and hypopharynx--Ear pain.
Nasopharynx--Trouble breathing or speaking, frequent headaches,
pain or ringing in the ears, or trouble hearing.
Larynx--Pain when swallowing, or ear pain.
Metastatic squamous neck cancer--Pain in the neck or throat that
does not go away.
These symptoms may be caused by cancer or by other, less serious
conditions. It is important to check with a doctor or dentist
about any of these symptoms.
Patients with head and neck cancers are usually treated by a team
of specialists. The specialists vary, depending on the location
and extent of the cancer. The medical team may include oral
surgeons; ear, nose, and throat surgeons (also called
otolaryngologists); pathologists; medical oncologists;
radiation oncologists; prosthodontists; dentists; plastic
surgeons; dietitians; social workers; nurses; physical therapists;
and speech-language pathologists (sometimes called speech
therapists).
8. How are head and neck cancers treated?
More information about radiation therapy is available in the
NCI booklet Radiation Therapy and You: A Guide to Self-Help
During Treatment. This booklet is available by calling the
Cancer Information Service (CIS) at 1-800-4-CANCER
(1-800-422-6237), or through the NCI Publications Locator Web
site at Http: //cancer.gov/publications on the Internet.
Chemotherapy. Anticancer drugs are used to kill cancer
cells throughout the body. Drugs used to treat head and neck
cancers are usually given by injection into the bloodstream
(intravenous, or IV). Chemotherapy is widely used to
treat certain stages of cancer of the nasopharynx,
hypopharynx, and salivary glands. Its use in treating other
head and neck cancers is being tested in clinical trials
(research studies). Chemotherapy may be combined with
radiation therapy to treat cancer of the nasopharynx.
The side effects of chemotherapy depend on the drugs that are
given. In general, anticancer drugs affect rapidly growing
cells, including blood cells that fight infection, cells that
line the mouth and the digestive tract, and cells in hair
follicles. As a result, patients may have side effects such
as lower resistance to infection, sores in the mouth and on
the lips, loss of appetite, nausea, vomiting, diarrhea, and
hair loss. They may also feel unusually tired and experience
skin rash and itching, joint pain, loss of balance, and
swelling of the feet or lower legs. Patients should talk with
their doctor or nurse about the side effects they are
experiencing, and how to handle them.
The NCI booklet Chemotherapy and You: A Guide to Self-Help
During Treatment has more information about this type of
treatment. This booklet is available by calling the CIS (see
below), or through the NCI Publications Locator at
Http: //cancer.gov/publications/ on the Internet.
Clinical trials are research studies conducted with people who
volunteer to take part. Participation in clinical trials is an
option for many patients with head and neck cancers.
Treatment trials are designed to find more effective cancer
treatments and better ways to use current treatments. In some
studies, all patients receive the new treatment. In others,
doctors compare different therapies by giving the new treatment to
one group of patients and standard therapy to another group.
Doctors are studying new types and schedules for delivering
radiation therapy, new anticancer drugs, new drug combinations,
and new ways of combining treatments. They are also studying ways
to treat head and neck cancers using biological therapy (a
type of treatment that stimulates the immune system to fight
cancer) by itself or in combination with anticancer drugs or
radiation therapy.
Scientists are also conducting clinical trials to find better ways
to reduce the side effects of chemotherapy and radiation therapy
for head and neck cancers. These clinical trials, called
supportive care trials, explore ways to improve the comfort
and quality of life of cancer patients and cancer survivors.
People interested in taking part in a clinical trial should talk
with their doctor. Information about clinical trials is available
from the CIS (see below) and the NCI booklet Taking Part in
Clinical Trials: What Cancer Patients Need To Know. This booklet
describes how research studies are carried out and explains their
possible benefits and risks. In addition, the NCIs Web site,
Http: //cancer.gov on the Internet, provides information about
clinical trials. It also offers detailed information about
specific ongoing studies by linking to PDQ, a cancer information
database developed by NCI. The CIS also provides information from
PDQ.
10. What rehabilitation or support options are available for patients
Rehabilitation is a very important part of treatment for patients
with head and neck cancer. The goals of rehabilitation depend on
the extent of the disease and the treatment a patient has
received. The health care team makes every effort to help the
patient return to normal activities as soon as possible.
Depending on the location of the cancer and the type of treatment,
rehabilitation may include physical therapy, dietary counseling,
speech therapy, and/or learning how to care for a stoma after a
laryngectomy. A stoma is an opening into the windpipe through
which a patient breathes after a laryngectomy.
Sometimes, especially with cancer of the oral cavity, a patient
may need reconstructive and plastic surgery to rebuild the bones
or tissues of the mouth. If this is not possible, a
prosthodontist may be able to make an artificial dental and/or
facial part (prosthesis) to restore satisfactory swallowing
and speech. Patients will receive special training to use the
device.
Patients who have trouble speaking after treatment, or who have
lost their ability to speak, may need speech therapy. Often, a
speech-language pathologist will visit the patient in the hospital
to plan therapy and teach speech exercises or alternative methods
of speaking. Speech therapy usually continues after the patient
returns home.
Eating may be difficult after treatment for head and neck cancer.
Some patients receive nutrients directly into a vein (IV) after
surgery, or need a feeding tube until they can eat on their own. A
feeding tube is a flexible plastic tube that is passed into the
stomach through the nose or an incision (cut) in the
abdomen. A nurse or speech-language pathologist can help
patients learn how to swallow again after surgery. The NCI booklet
Eating Hints for Cancer Patients: Before, During, and After
Treatment contains many useful suggestions and recipes. This
booklet is available from the CIS (see below), and through the NCI
Publications Locator at Http: //cancer.gov/publications on the
Internet.
The NCI fact sheet Questions and Answers About Followup Care has more information about this topic. This fact sheet is available from the CIS (see below), and through the NCI Publications Locator at Http: //cancer.gov/publications on the Internet.
People who have been treated for head and neck cancer have an
increased chance of developing a new cancer, usually in the head
and neck, esophagus, or lungs. The chance of a second primary
cancer varies depending on the original diagnosis, but is higher
for people who smoke. Patients who do not smoke should never
start. Those who smoke should do their best to quit. Studies have
shown that continuing to smoke increases the chance of a second
primary cancer for up to 20 years after the original diagnosis.
Information about smoking cessation is available from the CIS (see
below) and in the NCI fact sheet Questions and Answers About
Smoking Cessation. The fact sheet is available from the CIS (see
below), and through the NCI Publications Locator at
Http: //cancer.gov/publications on the Internet.
Some research has shown that isotretinoin (13-cis-retinoic
acid), a substance related to vitamin A, may reduce the risk
of a second primary cancer in patients who have been successfully
treated for cancers of the oral cavity, oropharynx, and larynx.
However, treatment with isotretinoin has not been shown to improve
survival.
You may want more information for yourself, your family, and your doctor. The following National Cancer Institute (NCI) services are available to help you.
Telephone...
Provides accurate, up-to-date information on cancer to patients and their families, health professionals, and the general public. Information specialists translate the latest scientific information into understandable language and respond in English, Spanish, or on TTY equipment.
Http: //cancer.gov - Cancer.gov is the NCI s primary web site and provides immediate access to critical cancer information and resources. It contains material for health professionals, patients, and the public, including information from PDQ about cancer treatment, screening, prevention, genetics, supportive care, and clinical trials, and CANCERLIT, a bibliographic database. Cancer.gov also includes information on understanding trials, deciding whether to participate in trials, finding specific trials, plus research news and other resources.
E-mail...
Includes NCI information about cancer treatment, screening, prevention, genetics, and supportive care. To obtain a contents list, send e-mail to cancermail@cips.nci.nih.gov with the word "help" in the body of the message.
Fax...
Includes NCI information about cancer treatment, screening, prevention, genetics, and supportive care. To obtain a contents list, dial 301-402-5874 or 1-800-624-2511 from a touch-tone telephone or fax machine hand set and follow the recorded instructions.
![]() |
Browse and Submit Oncology Conferences |
|
Sponsors:
|
small video clip about our work (200 Kbit/s)
|
| Back to the Cancernet
contents overview Questions? Mail them to us! |
of the Health On the Net Foundation
|